AGGIO CAT*PL GUIDE

The Sphynx ban in the Netherlands. Could new EU rules threaten breeding in Poland?

© · Aggio Cat*PL · aggiocat.pl

Since 1 January 2026, the Netherlands has prohibited the keeping of new hairless cats, including Canadian Sphynx cats. Other European countries impose restrictions on their breeding and participation in shows. Meanwhile, the European Union has adopted new rules on the welfare of dogs and cats, including provisions on exaggerated conformational traits. Could these rules threaten Sphynx breeding across Europe in the future?

The Sphynx ban in the Netherlands. What has actually changed?

On 1 January 2026, a regulation came into force in the Netherlands prohibiting the keeping of cats that permanently lack a functional coat or sensory hairs. The rules cover Canadian Sphynx cats, among others. Breeding animals with these traits had already been considered incompatible with Dutch welfare regulations, but the new provisions go considerably further, also covering their acquisition and keeping [1].

Existing owners may keep their cats for the rest of the animals’ lives if they meet the transitional requirements. In particular, they must have a document confirming that the animal was microchipped before the ban took effect. These cats may also be transferred to another keeper, but they may not be entered in shows or competitions.

The rules provide exceptions for activities including animal shelters, veterinary care and certain situations involving animal transport. Breaching the keeping ban carries an administrative fine of €1,500, while entering a cat covered by the restrictions in a show carries a fine of €500 [2].

Online, these regulations are often described as a ‘Sphynx ban in the Netherlands’. However, it is essential to distinguish between a breeding ban, a ban on keeping new cats and a ban on participation in shows: these are separate restrictions.

Dutch lawmakers concluded that the absence of a functional coat or whiskers has such serious welfare consequences that the continued keeping of animals with these traits should be prevented. In practice, the measure is intended to lead to the gradual disappearance of this group of cats in the Netherlands.

I do not question the need to protect animals from suffering. However, I have serious reservations about a measure that leaves no room to assess an individual cat’s health, physical abilities and actual functioning. A healthy, active Sphynx developing normally is covered by the same ban as an animal that has particular anatomical traits and also suffers from serious disease.

Why does the future of Sphynx cats in the European Union worry me more than the Dutch ban?

The Dutch decision itself is not my greatest concern. Individual countries pursue their own animal protection policies, and their laws need not be identical. What worries me much more is the possibility of a similar approach being adopted across the European Union.

Poland is also an EU member. If common rules were interpreted in the future in a way that excluded Sphynx cats from breeding, Polish breeders would also face the consequences, regardless of their experience, the extent of their health testing or the conditions in which their animals are kept.

We could reach a situation in which Sphynx cats continued to be bred in the United States, China, Russia, Ukraine and other non-EU countries, while European catteries gradually lost the ability to continue working with the breed. I am not saying this outcome is inevitable. I am concerned, however, that poorly defined welfare assessment criteria could lead to it.

This is about more than losing the opportunity to breed cats or take part in shows. It is also about the future of European breeding lines, maintaining genetic diversity and continuing efforts to improve the breed’s health.

New EU rules. What has already been adopted?

On 17 June 2026, the European Parliament and the Council adopted Regulation (EU) 2026/1818 on the welfare of dogs and cats and their traceability. It was published on 10 August 2026 and entered into force on 30 August. It will generally apply from 31 August 2028, although later dates are specified for some provisions [3].

The regulation introduces common requirements covering matters such as breeding establishments, housing conditions, identification, registration and trade. Many of these measures could help curb irresponsible breeding practices, which I have opposed for years.

For the future of Sphynx cats, however, Articles 8 and 19 are particularly significant.

Article 8(2) provides that operators of breeding establishments may not use dogs or cats for breeding if they have exaggerated conformational traits that lead to a high risk of detrimental effects on their welfare or that of their offspring. Before selecting an animal that may have such a trait for breeding, consultation with a veterinarian, or a suitably qualified person acting under a veterinarian’s responsibility, is required.

This provision is due to apply from 1 July 2030. It may also affect small catteries run in private homes if they meet the regulation’s definition of a breeding establishment.

Article 19 concerns shows, exhibitions and competitions. It restricts the participation of animals with exaggerated conformational traits for specified breeding and trading operators and requires organisers to exclude such animals from events. Under the current timetable, this provision is due to apply from 31 August 2028, earlier than the breeding restrictions.

The central question remains: exactly which traits will be considered exaggerated?

The regulation does not currently contain an exhaustive list of these traits, nor does it name the Sphynx as a banned breed. Article 8(3) empowers the European Commission to establish detailed criteria, assessment methods and documentation requirements through delegated acts to be adopted by 30 June 2030. In doing so, the Commission must take account of the scientific opinion of the European Food Safety Authority (EFSA), as well as the social and economic effects of the proposed measures.

The European Union has therefore not banned the breeding or keeping of Sphynx cats as a breed. It has adopted rules whose detailed application to particular anatomical traits will depend on future decisions.

I consider this stage especially important for the European cat fancy. If certain traits are deemed unacceptable without a sufficiently precise assessment of their actual effects on health and welfare, the consequences could be far-reaching.

© · Aggio Cat*PL · aggiocat.pl

What exactly is an exaggerated conformational trait?

Pedigree cats differ in size, body proportions, head shape, limb length and coat type. Some of these traits can indeed be associated with an increased risk of particular diseases. However, not every departure from the appearance of an average domestic cat constitutes a health disorder.

The key is therefore to establish when a characteristic physical trait becomes a cause of significant impairment of welfare.

The large size of a Maine Coon is one example. It does not automatically mean disease, although studies confirm links between certain aspects of conformation, body weight and the risk of hip dysplasia. There is no basis, however, for treating a cat’s size alone as evidence of suffering.

I expect the same distinction to be made for Sphynx cats. Their hairlessness is immediately visible, but appearance alone should not replace an assessment of actual health and functional consequences.

The new EU rules refer to a high risk of detrimental effects on welfare, which is an important criterion. It remains to be established how that risk will be assessed, which studies will be considered sufficient and whether differences between individual animals will be taken into account.

Does the absence of a coat necessarily mean suffering?

The Canadian Sphynx is a breed whose characteristic hairlessness originated in a spontaneous mutation. Research by Barbara Gandolfi, Leslie A. Lyons and colleagues, published in 2010, linked it to KRT71, a gene involved in normal hair structure [4].

A mutation’s natural origin does not establish that it is harmless, just as the presence of a mutation is not automatically evidence of disease. Its actual consequences should be what matters.

In 2014, David Genovese and colleagues published a histological study of Sphynx skin. They found that hair follicle density in the cats studied was similar to that in coated animals, but the structure of the follicles and the hairs they produced differed from normal. Hairlessness therefore does not mean a complete absence of the structures responsible for hair growth, but a disruption of their normal development [5].

A study by Xueting Qu and colleagues in 2022 also produced interesting findings. In samples taken from the neck region of two hairless Sphynx cats, skin thickness was approximately 1.91–1.95 mm, compared with 1.24 mm in the control cat. Differences in the epidermis and sebaceous glands were also observed [6].

However, the study involved very few animals, so it does not establish that all Sphynx cats have equally thick skin. Nor does it prove that skin thickness fully compensates for the absence of the coat’s insulating function.

What it does show is that Sphynx anatomy is more complex than appearance alone might suggest. Assessments of the welfare effects of hairlessness should also consider the structure and properties of the skin and subcutaneous tissue, physiological mechanisms and housing conditions.

From my own breeding experience, I am familiar with the distinctive resistance of Sphynx skin during certain injections. A veterinarian sometimes needs to apply greater force to insert the needle correctly. I do not regard this as scientific evidence of thicker skin or better thermal insulation, but as an observation suggesting that the skin of these cats may differ in its properties from that of coated animals.

Thermoregulation should be assessed in the same way. A Sphynx lacks a typical coat, which affects heat exchange with the environment. It therefore needs suitable environmental conditions and protection from chilling and excessive sun exposure. This does not mean, however, that it lacks physiological mechanisms for regulating body temperature.

Sphynx cats seek warm places, choose suitable beds and readily take opportunities to warm themselves. These are natural thermoregulatory behaviours. Their effectiveness under different conditions should be studied, but the need to provide a cat with a suitable environment is not, in itself, evidence of chronic suffering.

Whiskers: the greatest controversy surrounding Sphynx cats

Sensory hairs play important sensory roles in cats. They help cats explore their immediate surroundings, detect mechanical stimuli and respond to contact with objects. In Sphynx cats, whiskers may be short, curled, brittle or not visible.

On this basis, Dutch lawmakers concluded that animals without normal whiskers experience sensory limitations that impair their welfare.

However, I have serious doubts about directly transferring knowledge of whisker function in a typically coated cat to the assessment of an animal that has developed with differently formed sensory hairs from birth.

The feline nervous system uses multiple sources of information simultaneously, including vision, hearing, smell, touch and proprioception. The possibility of partial compensation for different sensory input is a biologically plausible hypothesis. However, its extent in Sphynx cats is not yet sufficiently understood.

For years, I have watched my cats jump, climb, run, negotiate obstacles and engage in complex play with remarkable precision. I do not observe problems with balance, coordination or spatial orientation. Many other breeders and owners of this breed describe similar experiences.

These observations cannot rule out every subtle difference in sensory functioning. They are, however, an important reason to conduct controlled studies establishing whether the absence of normal whiskers actually translates into a measurable reduction in quality of life.

This is not about denying the biological importance of whiskers. It is about establishing the actual consequences of their different structure for a Sphynx, rather than treating the anatomical difference alone as sufficient evidence of suffering.

Not all experts support bans covering entire breeds

Doubts about the justification for breed bans are not confined to breeders.

On 30 September 2022, the Brussels Animal Welfare Council issued an opinion on exaggerated conformational traits and hereditary disorders in dogs and cats. After hearing scientific experts and representatives of breeding organisations, a majority of the Council concluded that the actual welfare effects of certain traits, including hairlessness and the absence of whiskers, had not been sufficiently established [7].

The document highlighted the lack of sufficient studies to determine the frequency and severity of potential impairments and their effects on measurable welfare indicators. At that time, the Council’s majority did not recommend bans on entire breeds, apart from the particular case of Scottish Fold cats. Instead, it emphasised responsible breeding programmes, genetic testing and the preservation of genetic diversity.

However, the position was not unanimous. Separate minority opinions were attached, including those of the animal welfare organisations GAIA, La Croix Bleue de Belgique, Conseil National de Protection Animale and Help Animals, as well as representatives of the veterinary profession. Their authors supported stronger legal measures, including the possibility of banning the breeding of certain breeds or phenotypes, citing the need to protect animals effectively from suffering.

This lack of unanimity matters. It shows that even among professionals working in animal welfare, views differ on the appropriate protective measures.

At the same time, the majority position points to an alternative to immediate bans. Rather than eliminating entire breeds, it proposed scientifically validated breeding programmes, health monitoring and a gradual reduction in undesirable traits.

The argument concerning genetic diversity is particularly important. Excluding animals too broadly from breeding can narrow the gene pool and, in turn, increase the risk of other hereditary diseases.

Responsible breeding policy should therefore consider not only the removal of particular risks, but also the long-term consequences for the health of the population as a whole.

© · Aggio Cat*PL · aggiocat.pl

Welfare cannot be judged by appearance alone

I see a certain inconsistency in discussions of animal health. Anyone can see that a Sphynx has no coat, whereas diseases of the heart, joints or internal organs require specialist examinations. What is visible at first glance readily becomes a basis for judgement, even though it is not always a meaningful measure of suffering.

Studies show that healthy cats of different breeds can have different laboratory values. One example is the Birman, in which creatinine concentrations that are normal for the population may be higher than in other cats [9]. Hip dysplasia has been described in Maine Coons, yet cannot be diagnosed from appearance alone [8]. Non-pedigree cats also develop disease, including hypertrophic cardiomyopathy: the CatScan study detected HCM in 14.7% of 780 apparently healthy cats from rehoming centres [10].

These observations do not mean that all breeds have equal disease risks, or that visible physical traits cannot cause suffering. They show why physiological differences, disease predisposition and actual symptoms must be distinguished. I expect the same care to be taken in assessing the welfare of Sphynx cats.

Below, I have brought together 26 examples from the scientific literature covering healthy cats with different physiological characteristics, diseases in pedigree cats and conditions diagnosed in non-pedigree cats and the wider feline population. Clicking a group or study heading on the website expands the detailed findings, methodological limitations and a link to the original publication.

Some examples refer to the same publications, so 26 entries do not represent 26 independent studies. Diseases diagnosed in other cats provide comparative context, but do not in themselves prove that hairlessness or the absence of whiskers is harmless.

Scientific evidence: 26 examples

Natural physiological and genetic differences (8)

Examples showing why a result outside a general reference interval, or an unusual physical trait, does not necessarily mean disease.

1.1 Birman cats: higher creatinine and SDMA

In a comparison of 50 clinically healthy Birman cats and 46 cats of other breeds, mean creatinine concentrations were 1.58 and 1.19 mg/dl respectively, while SDMA concentrations were 12.2 and 10.3 µg/dl. In 20 of the 50 Birmans (40%), creatinine exceeded 1.6 mg/dl.

Limitations: The 1.6 mg/dl threshold is used to stage chronic kidney disease that has already been diagnosed, not to diagnose it on its own. The authors did not confirm that greater muscle mass explained the difference.

Source: Paltrinieri et al., 2018, Journal of Feline Medicine and Surgery

1.2 Abyssinian cats: smaller red blood cells

Microcytosis, meaning a smaller red blood cell volume, and higher concentrations of the alpha-2 globulin fraction have been described in clinically healthy Abyssinian cats.

Limitations: Blood count interpretation must take breed into account, but finding smaller erythrocytes does not rule out other diseases in an individual cat.

Source: Paltrinieri, Ibba and Rossi, 2014, Journal of Feline Medicine and Surgery

1.3 Norwegian Forest cats: ALP, calcium and phosphate

Healthy Norwegian Forest cats had ranges of alkaline phosphatase (ALP) activity and calcium and phosphate concentrations that differed from general reference intervals.

Limitations: This supports the use of breed-specific reference intervals. It does not mean that elevated ALP or disturbances of calcium and phosphate metabolism are always harmless.

Source: Paltrinieri, Ibba and Rossi, 2014

1.4 Siberian and Norwegian Forest cats: different globulin fractions

Some healthy cats of these breeds had lower beta-2 and gamma globulin concentrations than suggested by commonly used reference intervals.

Limitations: This finding cannot be used either to diagnose immunodeficiency or to assume its absence without the full clinical context.

Source: Paltrinieri, Ibba and Rossi, 2014

1.5 Four breeds and 536 healthy cats: 9 of 13 parameters were influenced by breed

In a study of Birman, Chartreux, Maine Coon and Persian cats, breed effects were demonstrated for 9 of 13 biochemical parameters. Differences in creatinine, glucose and total protein were potentially of particular clinical importance.

Limitations: The study concerned four breeds and a specific laboratory method, not all cats worldwide.

Source: Reynolds et al., 2010, Journal of Veterinary Internal Medicine

1.6 Devon Rex: a KRT71 mutation and a curly coat

The KRT71 variant responsible for the characteristic Devon Rex coat differs from the variant of this gene associated with hairlessness in the Canadian Sphynx.

Limitations: This demonstrates the molecular basis of different coat traits, not that every variant is equally neutral in its effects on welfare.

Source: Gandolfi et al., 2010, Mammalian Genome

1.7 Selkirk Rex: a distinct KRT71 variant and a curly coat

The Selkirk Rex’s curly coat is associated with another KRT71 variant. The OMIA database classifies this trait as a coat phenotype, not as an independently recognised disease.

Limitations: This does not automatically mean that the breed is entirely free of other health problems.

Source: Gandolfi et al., 2013, Scientific Reports; OMIA

1.8 Blood groups: substantial differences between breeds and regions

According to the ISFM guidelines, the proportions of blood groups A, B and AB depend on the population and breed. Group B can be relatively common in British Shorthairs, but its frequency also varies geographically in non-pedigree cats.

Limitations: A blood group is not a disease in itself. It is, however, important for transfusions and the risk of neonatal isoerythrolysis.

Source: Taylor et al., 2021, ISFM Consensus Guidelines

Diseases and predispositions in pedigree cats, often invisible at first glance (7)

Examples confirming that serious health problems need not arise from traits that are easy to see with the naked eye.

2.1 Maine Coon: hip dysplasia

A radiographic screening programme involving 5,038 Maine Coons detected changes consistent with hip dysplasia in 37.4% of participants. The severity of changes was associated with factors including age and body weight.

Limitations: This is the frequency of radiographic changes in the screened group, not the percentage of cats in constant pain or the worldwide prevalence of the disease.

Source: Low et al., 2019, Scientific Reports

2.2 Maine Coon: intestinal intussusception

In a retrospective analysis of 371 unwell Maine Coons at a veterinary clinic, 18 cases of intestinal intussusception were diagnosed, compared with none in a matched group of unwell control cats.

Limitations: The study involved clinic patients, not a representative sample of all Maine Coons. Intussusception also occurred in cats of other breeds.

Source: Dainese, Petini and Zoia, 2026, Journal of Small Animal Practice

2.3 Ragdoll: the MYBPC3 variant and hypertrophic cardiomyopathy

Research has shown an association between the MYBPC3:R820W variant and left ventricular wall thickness in Ragdolls. The disease may remain undetected without a cardiac examination.

Limitations: The presence of the variant alone does not establish the condition of an individual animal’s heart. Clinical examination and echocardiography are needed.

Source: The influence of clinical and genetic factors on left ventricular wall thickness in Ragdoll cats, 2015

2.4 Persian cats: PKD1-associated polycystic kidney disease

A PKD1 mutation associated with autosomal dominant polycystic kidney disease has been identified in Persian and related cats. The disease may develop before obvious symptoms appear.

Limitations: Historical data do not automatically reflect disease prevalence in modern catteries that use genetic testing.

Source: Lyons et al., 2004, Journal of the American Society of Nephrology

2.5 Burmese cats: feline orofacial pain syndrome

In a series of 113 cats with feline orofacial pain syndrome (FOPS), 100 were Burmese. Painful episodes involving the mouth and self-inflicted tongue injuries were described.

Limitations: This is a clinical case series, not an estimate of FOPS prevalence throughout the breed. An inherited predisposition was suspected, but the mechanism was not definitively established.

Source: Rusbridge et al., 2010, Journal of Feline Medicine and Surgery

2.6 Burmese, Tonkinese and Norwegian Forest cats: diabetes mellitus

In an analysis of 194,563 cats attending UK veterinary practices, Tonkinese, Norwegian Forest and Burmese cats had higher adjusted odds of a diabetes diagnosis than crossbred cats.

Limitations: Risk also depended on age, body weight and other factors. This is not evidence that every cat of these breeds will develop diabetes.

Source: Epidemiology of Diabetes Mellitus among 193,435 Cats, 2016, Journal of Veterinary Internal Medicine

2.7 Sphynx cats: HCM is a real risk that must not be concealed

A New Zealand study following 55 Sphynx cats confirmed a substantial occurrence of HCM diagnoses in the group studied. This supports regular cardiac screening and careful breeding decisions.

Limitations: The result is not the worldwide prevalence of HCM in the breed. HCM and the KRT71 mutation responsible for hairlessness are separate issues.

Source: Seo et al., 2024, Animals

Non-pedigree cats and the wider feline population: they develop disease too (11)

Studies involving crossbred cats, cats from rehoming centres or broad populations. Where a sample did not consist exclusively of non-pedigree cats, this is explicitly stated.

3.1 HCM: 14.7% in a study of cats from rehoming centres

The CatScan study performed echocardiographic examinations on 780 apparently healthy cats from rehoming centres. Hypertrophic cardiomyopathy was detected in 14.7%.

Limitations: The sample did not consist exclusively of non-pedigree cats. The result is not a universal disease prevalence for all non-pedigree cats.

Source: Payne et al., 2015, CatScan study

3.2 Hyperthyroidism: higher risk in non-pedigree cats in the population studied

Among 95,629 cats in the study, 2,276 cases of hyperthyroidism were diagnosed. After adjustment for other factors, pedigree cats had lower odds of diagnosis than non-pedigree cats (OR 0.33).

Limitations: These findings concern a UK population receiving veterinary care; disease prevalence increased markedly with age. They do not demonstrate that pedigree cats are generally healthier.

Source: Stephens et al., 2014, Veterinary Record

3.3 Periodontal disease: 15.4% among 15,841 crossbred cats

In a VetCompass study of 18,249 cats, periodontal disease was diagnosed in 2,442 of 15,841 crossbred cats, or 15.4%.

Limitations: Periodontal disease also affects pedigree cats. In this study, pedigree status itself was not a significant risk factor after adjustment for other variables.

Source: O’Neill et al., 2023, Journal of Feline Medicine and Surgery

3.4 Abscesses and hyperthyroidism in a study of 3,584 cats

In a random sample of 3,584 cats from a population of 142,576 veterinary patients, non-bite abscesses and hyperthyroidism were recorded more frequently in crossbred cats than in pedigree cats.

Limitations: This compared the 20 most common diagnoses, rather than assessing every possible disease. Coat problems were more common in pedigree cats.

Source: O’Neill et al., 2014, The Veterinary Journal

3.5 Inherited disease variants also occur in non-pedigree cats

A DNA panel study of 11,036 cats, including 617 non-pedigree cats, detected disease-associated variants in both populations. Three disease variants were found only in the non-pedigree group studied.

Limitations: Detecting a variant does not necessarily mean that symptomatic disease is present. The non-pedigree group was much smaller than the pedigree group.

Source: Anderson et al., 2022, PLOS Genetics

3.6 Myotonia, hyperoxaluria type II and lipoprotein lipase deficiency

In the genetic study by Anderson and colleagues, variants associated with these three diseases were detected only in the non-pedigree subgroup analysed.

Limitations: This does not mean that these diseases occur exclusively in non-pedigree cats worldwide, or that all carriers of the variants become ill.

Source: Anderson et al., 2022, PLOS Genetics

3.7 Diabetes mellitus: over a thousand diagnoses in crossbred cats

In a UK population of 194,563 cats, diabetes was diagnosed in 1,006 of the 173,578 cats classified as crossbred, or 0.58%.

Limitations: This finding describes the prevalence of diagnoses in veterinary practices; it does not mean that crossbred cats had a higher diabetes risk than every pedigree breed.

Source: Epidemiology of Diabetes Mellitus among 193,435 Cats, 2016

3.8 Degenerative joint changes: 90% in 100 older cats

In a retrospective radiographic analysis of 100 cats over 12 years of age, degenerative changes were identified in 90 animals.

Limitations: The study concerned geriatric cats, not exclusively non-pedigree cats. Radiographic changes do not necessarily mean chronic pain in every animal.

Source: Hardie, Roe and Martin, 2002, JAVMA

3.9 Upper urinary tract stones also occur in non-pedigree cats

An analysis of 11,431 patients at a UK referral centre found no significant overall difference in the prevalence of upper urinary tract urolithiasis between pedigree cats as a single group and non-pedigree cats.

Limitations: Risk depended on the particular breed. The study involved patients referred to a specialist centre, not the general population.

Source: Geddes et al., 2023, Journal of Veterinary Internal Medicine

3.10 Lifespan: an advantage for crossbred cats in UK VetCompass data

In a life-table study based on 7,936 confirmed deaths, life expectancy at birth was 11.89 years for crossbred cats and 10.41 years for pedigree cats as a group.

Limitations: This important finding runs counter to the simplistic claim that all populations have similar health. Individual breeds differed substantially, and the number of recorded deaths was small for some breeds.

Source: Teng et al., 2024, Journal of Feline Medicine and Surgery

3.11 More than 1.6 million cat-years of observation in Sweden

A study of insured cats in Sweden compared morbidity in crossbred and pedigree cats across 24 disease categories. For pedigree cats as a group, higher relative risks included heart disease, lower respiratory tract disease and immune disorders.

Limitations: This is an important qualification: not all findings point to better health in pedigree cats. The data come from insurance records and depend on claims-reporting practices.

Source: Hadar et al., 2023, Veterinary Record

Important: percentages, odds ratios (OR), the frequency of imaging findings and the prevalence of clinical disease are not interchangeable measures. They must not be compared without considering study designs and the populations studied.

We must not conceal the real health problems of Sphynx cats

Defending Sphynx cats cannot mean denying their health predispositions. That would undermine the credibility of the entire argument.

Hypertrophic cardiomyopathy (HCM) remains a particularly important risk. In a New Zealand study published in 2024 by Joonbum Seo and colleagues, HCM was diagnosed in 20 of the 55 Sphynx cats followed over the period covering the initial examination and subsequent follow-up. This finding concerns a specific population and should not automatically be applied to all cats of the breed, but it provides an important argument for systematic cardiac screening [11].

The same study did not confirm an association between the ALMS1 gene variant investigated and an HCM diagnosis. This illustrates the importance of distinguishing established genetic associations from those requiring further verification.

The UK VetCompass study of feline lifespan, published in 2024, must also be considered. It estimated Sphynx life expectancy at birth at 6.68 years. However, this estimate was based on just 18 recorded deaths and had a wide confidence interval, limiting its generalisability to the breed’s entire population [12].

Dermatological studies have described, among other findings, more frequent colonisation of Sphynx skin by Malassezia yeasts. In the 2009 study by Åhman and Bergström, these yeasts were detected in 26 of the 32 Sphynx cats examined. The presence of yeast alone did not, however, mean that all these animals had active skin disease [13].

These findings deserve attention and should inform responsible breeding. However, without demonstrating the relevant causal links, it is not valid to attribute every Sphynx health problem to the mutation responsible for hairlessness.

In my cattery, I have long placed great importance on regular cardiac examinations, genetic and diagnostic testing, and monitoring the health of successive generations. I believe responsible breeding should consist of identifying threats and gradually reducing risk, rather than claiming that members of a particular breed never become ill.

Germany, Austria and Switzerland. What restrictions are already in place?

The Netherlands is not the only European country imposing restrictions on Sphynx cats. However, national rules differ in scope and should not be presented as a single common ban.

In Germany, action against certain breeding practices is based on section 11b of the Animal Welfare Act (Tierschutzgesetz), concerning so-called Qualzucht: breeding that produces inherited changes causing pain, suffering or damage to health.

On 13 April 2026, in interim relief proceedings, the Higher Administrative Court of Rhineland-Palatinate upheld an order requiring the surgical castration of two Canadian Sphynx cats. The court held that the absence of functional whiskers justified applying the rules on breeding that causes suffering. The ruling was described in an official press release dated 21 April 2026 [14].

This does not amount to a nationwide ban on keeping all Sphynx cats in Germany. It does show how serious the consequences for breeders can be when particular anatomical traits are interpreted in this way.

In Austria, section 8b of the Animal Welfare Act has applied since 1 January 2025. It prohibits the exhibition and presentation of animals with symptoms or external traits classified as associated with breeding that causes suffering. It also restricts the use of images of animals with such traits in advertising [15].

In Switzerland, official guidance from the Federal Food Safety and Veterinary Office (BLV) restricts participation in shows by cats with missing or underdeveloped sensory hairs. Sphynx cats and certain Rex breeds are specifically mentioned [16].

Each country applies its own rules. A common theme, however, is the growing legal scrutiny of anatomical traits that have been characteristic features of recognised cat breeds for many years.

The work of the FIFe Sphynx Breed Council

Restrictions on Sphynx cats have also been addressed within the Fédération Internationale Féline.

In November 2025, acting as secretary of the FIFe Sphynx Breed Council, I wrote to the federation’s Board on the Council’s behalf with proposals to address the exclusion of recognised breeds from major international shows [17]. One request was that World Shows should be planned in countries whose laws allow all FIFe-recognised breeds to participate. In its response of 30 January 2026, the Board cited the need to comply with national law and the limited scope for arranging alternative forms of cat presentation. In my view, this did not resolve the underlying problem: although the federation cannot control national legislation, it chooses the organisers of its most important events. The Polish Felinological Federation Felis Polonia made a similar attempt to address the issue in May 2026, proposing an amendment to the FIFe Show Rules that would prohibit World Shows and Winner Shows in countries where not all recognised breeds may be exhibited. The proposal was rejected by 28 votes against to 10 in favour, with two abstentions [21]. For me, this remains an important question of equal treatment of breeds and exhibitors within a single international federation.

The Council also requested clarification of the Sphynx standard regarding the natural absence or altered structure of whiskers, and a scientific initiative on hairlessness and sensory hair morphology.

In January 2026, following the position of the Judges & Standards Commission, the FIFe Board did not accept the proposed clarification of the standard concerning whiskers [18].

The interpretation of FIFe’s current breeding rules remains important. Section 3.6 lists cats without whiskers among those not permitted for breeding. At the same time, FIFe recognises the Sphynx, whose standard reflects its characteristic sensory hair structure. Distinguishing the complete absence of whiskers from their presence in a short or brittle form also requires precision in the federation’s practice [19].

The development of scientific work is a positive step. In January 2026, the FIFe Board approved one-off funding for three research grants of €3,000 each, covering hairlessness, brachycephaly and whiskers. Funding alone does not mean that the research has been completed or that results are available, but it is a concrete form of support for further work.

© · Aggio Cat*PL · aggiocat.pl

Polish researchers will study Sphynx welfare. Aggio Cat*PL cats will take part too

Of particular importance to me is the project ‘Does the phenotype of Rex and Sphynx cats affect their health and welfare?’, scheduled to begin on 1 November 2026 at the Warsaw University of Life Sciences (SGGW).

The project is being carried out in cooperation with PFF Felis Polonia, with funding from the FIFe Feline Fund. It will assess health, physical abilities, behaviour and responses to stressors. Participants will include Canadian Sphynx, Don Sphynx, Peterbald, Devon Rex and Cornish Rex cats. Domestic and British cats are planned as the control group [20].

Cats from my Aggio Cat*PL cattery are also expected to participate in the project.

I want their abilities and behaviour to be assessed by scientists. I do not want to base the defence of Sphynx cats solely on many years of breeding observations, although I consider these a valuable source of practical knowledge.

I do not intend to prejudge the findings. If the research reveals genuine functional limitations, we will need to understand them and take them into account in our breeding work. If it does not confirm the impairments attributed to Sphynx cats, those findings should also inform the development of welfare assessment standards.

That is what I expect from sound science: testing hypotheses and drawing conclusions from the data obtained, rather than confirming pre-existing beliefs.

The future of Sphynx cats in Europe depends on knowledge, not stereotypes

What concerns me most in this discussion is the possibility of equating a particular appearance with inevitable suffering.

This does not mean that visible anatomical traits cannot cause serious health problems. Some do cause pain, restricted movement or impaired functioning. In such cases, appropriate protective action is necessary.

However, welfare assessment should consider actual health and behavioural consequences, their severity and frequency, and the scope for reducing risk through proper care and responsible breeding selection.

Over my years of working with Sphynx cats, I have come to know active, intelligent cats that form exceptionally close relationships with people. Their unusual appearance draws attention, but to me their character is their most beautiful quality. Sphynx cats seek contact and show affection and attachment. They want to be involved in our lives, accompany us in everyday activities and simply be close.

Their facial expressions fascinate me too. Sphynx cats have expressive faces; in their eyes and gestures I see curiosity, contentment, surprise and sometimes an almost theatrical indignation. Although I have had the opportunity to get to know many cats, I have not encountered another breed that seeks human closeness in quite the same way.

This is why I find it difficult to accept a discussion of these animals’ future that focuses almost exclusively on what they supposedly lack. Anyone who knows Sphynx cats knows that their remarkable qualities go beyond appearance. Their temperament, sensitivity and capacity to bond with people are also part of what makes them special.

The future of EU rules worries me much more than the Dutch ban. Detailed criteria for exaggerated conformational traits have not yet been finalised. How they are framed could have significant implications for Sphynx breeding and other breeds in Poland and across the European Union.

I would not want Sphynx cats to continue thriving in catteries on other continents while European breeders lost the ability to work with the breed because of rules that gave insufficient weight to scientific evidence and animals’ actual quality of life.

In my view, the right way forward is to expand research, improve preventive care, hold breeders accountable and develop precise criteria for assessing welfare.

Let us fight disease, suffering and ignorance—not appearance.

Sources and documents

Dutch and EU legislation

[1] Netherlands, Staatsblad 2025, No. 288. Decree of 9 October 2025 and its explanatory memorandum, Articles 3.33–3.36.

[2] Rijksdienst voor Ondernemend Nederland (RVO). Houdverbod naaktkatten en vouwoorkatten. Official information on the ban and its exceptions.

[3] Regulation (EU) 2026/1818 of the European Parliament and of the Council of 17 June 2026 on the welfare of dogs and cats and their traceability, particularly Articles 3, 5, 8, 19, 30 and 33.

Sphynx genetics, skin and health

[4] Gandolfi B. et al. (2010). The naked truth: Sphynx and Devon Rex cat breed mutations in KRT71. Mammalian Genome. DOI: 10.1007/s00335-010-9290-6.

[5] Genovese D.W. et al. (2014). Histological and dermatoscopic description of sphynx cat skin. Veterinary Dermatology. DOI: 10.1111/vde.12162.

[6] Qu X. et al. (2022). Skin Transcriptome Analysis of Sphynx and Haired Sphynx Mutant Cats. Journal of Animal Biology and Veterinary Medicine.

[7] Brussels Animal Welfare Council (2022). Avis concernant une législation par rapport aux hypertypes et troubles héréditaires chez les chiens et les chats, 30 September 2022, including minority opinions.

[8] Low M. et al. (2019). Demography, heritability and genetic correlation of feline hip dysplasia and response to selection in a health screening programme. Scientific Reports. DOI: 10.1038/s41598-019-53904-w.

[9] Paltrinieri S., Giraldi M., Prolo A. et al. (2018). Serum symmetric dimethylarginine and creatinine in Birman cats compared with cats of other breeds. Journal of Feline Medicine and Surgery, 20(10), 905–912. DOI: 10.1177/1098612X17734066.

[10] Payne J.R., Brodbelt D.C., Luis Fuentes V. (2015). Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study). Journal of Veterinary Cardiology. DOI: 10.1016/j.jvc.2015.03.008.

[11] Seo J. et al. (2024). Prevalence of Hypertrophic Cardiomyopathy and ALMS1 Variant in Sphynx Cats in New Zealand. Animals. DOI: 10.3390/ani14182629.

[12] Teng K.T. et al. (2024). Life tables of annual life expectancy and risk factors for mortality in cats in the UK. Journal of Feline Medicine and Surgery. DOI: 10.1177/1098612X241234556.

[13] Åhman S.E., Bergström K.E. (2009). Cutaneous carriage of Malassezia species in healthy and seborrhoeic Sphynx cats and a comparison to carriage in Devon Rex cats. Journal of Feline Medicine and Surgery. DOI: 10.1016/j.jfms.2009.04.011.

Rules in other countries

[14] Germany, Oberverwaltungsgericht Rheinland-Pfalz. Kastration zweier Katzen der Rasse Canadian Sphynx, press release of 21 April 2026, order of 13 April 2026, case No. 7 B 10250/26.OVG.

[15] Austria, Tierschutzgesetz, section 8b. Prohibition on exhibiting animals with traits classified as associated with breeding that causes suffering, and on certain uses of their images.

[16] Switzerland, Bundesamt für Lebensmittelsicherheit und Veterinärwesen (BLV). Fachinformation Tierschutz Nr. 18.3: Katzenausstellungen, January 2021, p. 3.

FIFe documents and SGGW research

[17] FIFe, minutes of the Board meeting of 22 November 2025, item 12: Breed Councils, p. 5.

[18] FIFe, minutes of the Board meeting of 20 January 2026, items 5.2, 13.3 and 13.4.

[19] FIFe, Breeding & Registration Rules, version dated 1 July 2026, section 3.6: Cats not allowed for breeding.

[20] Cat Club Animals / PFF Felis Polonia, announcement of 5 October 2026 concerning the SGGW research project funded by the FIFe Feline Fund.

[21] FIFe, General Assembly 2026, FPL proposal No. 2 concerning section 2.7.f and the voting record, p. 50. FIFe GA 2026 minutes (PDF).

Legal position and state of knowledge as of 30 October 2026.

© · Aggio Cat*PL · aggiocat.pl